JMY is involved in anterograde vesicle trafficking from the trans-Golgi network  by Schlüter, Kai et al.
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Junction-mediating  and  regulatory  protein  (JMY)  was  originally  identiﬁed  as  a transcriptional  co-factor  in
the  p53-response  to DNA  damage.  Aside  from  this  nuclear  function,  recent  years  have  uncovered  an  addi-
tional function  of  JMY, namely  in  cytoskeleton  remodelling  and  actin  assembly.  The  C-terminus  of JMY
comprises  a canonical  VCA-module,  the  sequence  signature  of  Arp2/3  complex  activators.  Furthermore,
tandem  repeats  of  3  WH2  (V, or more  recently  also W)  domains  render  JMY  capable  of Arp2/3  indepen-
dent  actin  assembly.  The  motility  promoting  cytoplasmic  function  of JMY  is  abrogated  upon  DNA-damage
and  nuclear  translocation  of  JMY.
To address  the  precise  cellular  function  of JMY  in  cellular  actin  rearrangements,  we have  searched  for
potential  new  interaction  partners  by  mass  spectrometry.  We  identiﬁed  several  candidates  and  correlated
their  localization  with  the  subcellular  dynamics  of  JMY.  JMY  is localized  to dynamic  vesiculo-tubular
structures  throughout  the  cytoplasm,  which  are decorated  with  actin  and  Arp2/3  complex.  Moreover,  JMYesicle trafﬁc
ubular vesicles
olgi
partially  colocalizes  and  interacts  with  VAP-A,  which  is  involved  in vesicle-based  transport  processes.
Finally,  overexpression  of JMY results  in  Golgi  dispersal  by loss  from  the  trans-site  and affects  VSV-G
transport.  These  analyses,  together  with  biochemical  experiments,  indicate  that JMY  drives  vesicular
trafﬁcking  in  the  trans-Golgi  region  and  at ER-membrane  contact  sites  (MCS),  distinct  from  other  Arp2/3
activators  involved  in vesicle  transport  processes  such  as the  related  WHAMM  or WASH.
© 2014  The  Authors.  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  CCntroduction
Junction-mediating and regulatory protein (JMY) was  originally
dentiﬁed as a transcription co-factor binding to p300-protein,
hich is involved in positively regulating the p53 response
Shikama et al., 1999). Moreover, JMY  is targeted for degradation
o disallow it from activating p53 by binding to the prominent
53 regulator Mdm2,  until DNA damage signals its release (Coutts
t al., 2007). In DNA damage conditions, JMY  undergoes nuclear
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accumulation, which drives the p53 transcription response. In the
cytoplasm, however, JMY  was  ascribed a role in cell motility by (i)
directly driving actin nucleation at the cell front (Zuchero et al.,
2009) and (ii) indirectly by negatively regulating cell–cell adhesion
through suppression of cadherin expression (Coutts et al., 2009).
Cellular processes that were assigned to JMY  are as diverse as the
suppression of neuritogenesis (Firat-Karalar et al., 2011) or cytoki-
nesis in mouse oocytes, where it might act as upstream-regulator of
Arp2/3-complex in asymmetric division (Liu et al., 2012). Nonethe-
less, the exact (sub-)cellular processes and the basic mechanisms
underlying these ﬁndings are not well deﬁned.
Sequence analysis groups JMY  to both families, the tandem
monomer-binding nucleators as well as the canonical class I acti-
vators of Arp2/3 complex (Coutts et al., 2010; Firat-Karalar and
Welch, 2011; Rottner et al., 2010). Hence, JMY  can contribute to
actin assembly in Arp2/3-dependent as well as -independent ways:
JMY  comprises a C-terminal VCA module that comprises a g-actin
s article under the CC BY-NC-SA license (http://creativecommons.org/licenses/
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inding Verprolin-homology (V- or WH2) domain, a central con-
ectin (C) motif and a C-terminal acidic (A) motif for Arp2/3 binding.
his canonical VCA-moduele has consequently been shown to be
apable of activating the Arp2/3 complex (Coutts et al., 2009;
uchero et al., 2009). In addition however, the C-terminus of JMY
arbours two additional WH2  domains, which, in concert with
he third WH2  domain, can initiate Arp2/3 independent nuclea-
ion, probably similar to Spire (Coutts et al., 2009; Zuchero et al.,
009). The major portion of JMY, which has a molecular weight
f approx. 110 kDa, constitutes the central coiled coil domain,
nd is related to that found in the paralogous protein WHAMM
Campellone et al., 2008; Firat-Karalar and Welch, 2011). Hence,
MY  and WHAMM  form a subfamily within the group of class 1
ucleation promoting factors (NPFs) (Veltman and Insall, 2010).
owever, while WHAMM  can also activate Arp2/3 complex, it
acks additional WH2  domains for Arp2/3-independent nuclea-
ion. Finally, WHAMM  was found to drive vesicle trafﬁc between
he ER and the Golgi, a cellular compartment called ERGIC (ER-
olgi-Intermediate-Compartment), where it was  required mainly
or Arp2/3-dependent transport between these compartments
Campellone et al., 2008).
We  here show that JMY  is localized to tubular vesicles in the
ytoplasm, where it drives actin dependent anterograde trafﬁc-
ing away from the trans-Golgi face. Overexpression of JMY  affects
ntegrity of the Golgi and impairs trafﬁcking of the stomatitis indi-
na virus envelope glycoprotein VSV-G to the plasma membrane.
inally, when screening for interaction partners, we  found that JMY
nteracts with the vesicle-associated membrane protein-associated
rotein A (VAP-A) at sites reminiscent of membrane contact sites
MCS) that are formed between the peripheral ER and other cellular
embranes (Friedman and Voeltz, 2011).
aterials and methods
ntibodies, expression constructs and reagents
GFP-JMY-full length construct was obtained by PCR from the
urine cDNA-full length clone #IRAKp961B15195Q (Source Bio-
cience). JMY  deletion mutants and domains were cloned from the
FP-JMY-FL plasmid via PCR as indicated in Table S1 and ligated
nto pEGFP-C1 expression vector (Clontech). Murine VAP-A was
loned from the cDNA full length clone #IRAVp968F054D (Source
ioScience). GFP-tagged full length WHAMM  was  as described and
indly provided by Matthew D. Welch (Campellone et al., 2008).
SV-G temperature sensitive mutant GFP-VSV-G ts045 was  as
escribed (Toomre et al., 1999). GFP-ER was subcloned from the
riginal Clontech pEYFP-ER. Plasmids were maintained in E. coli
H5 (life technologies). Commercial primary antibodies were as
ollows: rabbit polyclonal anti-JMY (ab#1: ab69945; Abcam); goat
olyclonal anti-JMY (#ab2: sc-10027; Santa Cruz); rabbit poly-
lonal anti-ERGIC53 (#E1031; Sigma–Aldrich); mouse monoclonal
nti-GM130 (#610823; BD Transduction Laboratories); rabbit
olyclonal anti-TGN46 (#PAB0110; Abnova); mouse anti-VSV-G
ctodomain antibody was kindly provided by Jean Gruenberg (Uni-
ersity of Geneva). Anti myc  was from Abcam (#9E10) and anti GFP
as from Synaptic Systems (#101G4). Alexa-Fluor-594-labelled
halloidin and antibodies as used in immunoﬂuorescence stain-
ngs were obtained from Life Technologies. HRP-coupled antibodies
sed in Western-Blot experiments were from Dianova.
ells, treatments and transfectionsCOS-7 cells (DSMZ; #ACC 60) were grown in DMEM,  4.5 g/L
lucose (Life Technologies) with 10% FCS (Sigma–Aldrich), 2 mM
lutamine and 50 U/ml Penicillin/Streptomycin (Life Technologies)Cell Biology 93 (2014) 194–204 195
at 37 ◦C and 5% CO2. HeLa cells (ATCC; #CCL-2) were grown in MEM
with Earle’s salts (Life Technologies) with 10% FCS (Sigma–Aldrich),
2 mM glutamine, 1 mM sodium pyruvate, non-essential amino
acids and 50 U/ml Penicillin/Streptomycin (Life Technologies)
at 37 ◦C and 5% CO2. Transfections were carried out with X-
tremeGene 9 (Roche), according to the manufacturer’ protocols.
For microscopy, cells were transfected in a 3 cm diameter dish and
plated to 15 mm glass coverslips on the next day. For immunopre-
cipitations (IPs), cells were transfected in a 10 cm diameter dish
and processed after 16–24 h.
Immunoprecipitation
For IPs, transfected cells were washed once with PBS, lysed
in 1 ml  ice-cold lysis buffer (8 mM Tris base, 12 mM HEPES, pH
7.5, 50 mM NaCl, 15 mM KCl, 3 mM MgCl2, 1% Triton X-100, and
EDTA-free protease inhibitor cocktail Complete Mini (Roche)) for
20 min  on ice. Clariﬁcation of the lysates was performed for
15 min  at 12,000 × g. After removing a sample as loading control,
supernatants were incubated for 2 h in a spinning wheel at 4 ◦C. G-
Sepharose slurry was equilibrated two times in IP-Buffer (8 mM Tris
base, 12 mM HEPES, pH 7.5, 50 mM NaCl, 15 mM KCl, 3 mM MgCl2).
30 l of equilibrated G-Sepharose slurry was added to supernatants
and incubated for additional 45 min  at 4 ◦C. Bead material was
separated by centrifugation for 2 min  at 500 × g and a sample for
Western-Blot analysis prepared. The resulting pellet was  washed
twice in IP-buffer without Triton-X-100, supplemented with SDS
sample-buffer and stored at −20 ◦C. Western Blots were developed
using HRP-labelled secondary antibodies, LumiLight (Roche), and
images were acquired using a GeLiance imaging system (Perkin
Elmer).
VSV-G transport assay
To determine the rate of GFP-VSV-G transport, 2 × 105 HeLa cells
grown on glass cover slips were transfected either with pEGFP-
VSVG3 alone or together with myc-tagged JMY  using Turbofect®
(Thermo Fisher Scientiﬁc, Germany) according to the manufac-
turer’s instructions. After 6–14 h at 37 ◦C, cells were shifted to
39.5 ◦C for 24 h. VSV-G transport was  induced by replacing culture
media with media containing 10 mg/ml  cycloheximide at 32 ◦C.
After 1 h, cells were washed 3× with ice cold PBS and ﬁxed in
8% PFA for 10 min  on ice followed by an additional ﬁxation step
using 4% PFA at room temperature. Fixed cells were washed thrice
with PBS and incubated with 50 mM NH4Cl for 5 min. VSV-G at the
plasma membrane was stained in non-permeabilized cells using
an anti-VSV-G ectodomain speciﬁc antibody. Myc-JMY-expression
was conﬁrmed by permeabilizing and staining parallel samples
with rabbit anti myc  (A14, Santa Cruz Biotechnology), revealing a
co-expression in more than 95% of the GFP-VSV-G-expressing cells
(not shown). The secondary antibody was  goat anti-mouse Oys-
ter594 (Luminartis, Münster, Germany). Cells were analysed using
a Leitz Diaplan microscope equipped with an Olympus XM10 cam-
era. For image analysis, ImageJ (Schneider et al., 2012) was  used.
GFP-VSV-G positive cells were outlined manually, and the mean
grey values of green (IVSV-G) and red (Iecto) channels were mea-
sured. Background levels were assessed from non-transfected cells
in the same image and subtracted. Transport rates were calculated
by dividing the corrected values of Iecto by IVSV-G.
Fluorescence microscopy
For immunoﬂuorescence, cells grown on ﬁbronectin were ﬁxed
with pre-warmed formaldehyde (4%) in PBS for 20 min, extracted
with 0.1% Triton X-100 (1 min), and stained with the indicated
antibodies and/or phalloidin. Effects of JMY  and mutants were
quantiﬁed by assessing the percentage of GFP-tagged JMY  variant
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xpressing cells showing either endomembrane tubules (ETs) or
loudy accumulations (clouds). Integrity of the Golgi was  classiﬁed
s ‘unaffected’ when the staining was compact and round in the
erinuclear region and as (ii) ‘affected’ when the staining was either
ispersed around the nucleus or extending into the cytoplasm by
/3 of the distance between Golgi and cell edge. Assessment of
he effects of nocodazole (noco) or latrunculin B (latB) was per-
ormed as follows: Cells growing on coverslips and expressing
FP-JMY were treated with vehicle or either 1 g/ml noco or vary-
ng concentrations of latB for 1 h, ﬁxed and stained with tubulin
ntibodies or phalloidin to monitor the dissolution of microtubules
nd F-actin, respectively. All images were acquired with an inverted
icroscope (Axiovert 200, Zeiss) equipped with standard epiﬂuo-
escent illumination and 63×/1.25NA or 100×/1.3NA plan-Neoﬂuar
bjectives, and a back-illuminated, cooled charge-coupled-device
amera (Sensicam) driven by Visiview (Visitron) software. High-
agniﬁcation video microscopy was performed with cells mounted
n an open, heated chamber (Warner Instruments) as described
Steffen et al., 2004). All microscopy images were processed further
ith ImageJ or Adobe Photoshop 7.0/CS software (Adobe Systems).
andem afﬁnity puriﬁcation of JMY  associated proteins
Mouse JMY  ORF was cloned into pcDNA5 His-PC-TEV blue plas-
id  (Derivery et al., 2009b) between the FseI and AscI sites. This
lasmid, or the blue control, was used to derive a stable cell line
rom Flp-In T-Rex 293 cells (Invitrogen). These lines were selected
nd grown in spinner cultures as described (Derivery and Gautreau,
010). About 5E09 cells from 3 L of culture were lysed in buffer 1
50 mM HEPES pH 7.7, 150 mM KCl, 1% NP-40, 0.5% Deoxycholate,
.1% SDS, 1 mM  CaCl2 supplemented with Protease Inhibitor Cock-
ail (Sigma)). Lysate was incubated with 1 ml  sepharose beads
ross-linked to 4 mg  of HPC-4 mAb  that recognizes the PC epitope
ag. HPC-4 beads were washed extensively with 50 mM HEPES pH
.7, 150 mM KCl, 5% glycerol and eluted in 10 ml  of the same buffer
ontaining 5 mM  EGTA. The eluate was then dialyzed against buffer
 (50 mM HEPES pH 7.7, 150 mM KCl, 5% glycerol, 30 mM imidazole,
 mM DTT) and then incubated with 50 l of Ni-sepharose beads
High performance, GE healthcare). Ni-beads were washed exten-
ively with buffer 2 and resuspended in SDS-PAGE loading buffer.
amples were run on Bis-Tris 4–12% gradient gel (Life technologies)
tained with colloidal coomassie. Bands were cut and analysed by
anoLC-MS/MS as described (Lebreton et al., 2011).
esults
MY  expression and subcellular distribution
Gene Chip analyses revealed the expression levels of JMY, the
elated protein WHAMM  and WASH in a number of tissue culture
ell lines (Fig. 1a). The expression pattern of other class I NPFs has
een described (Block et al., 2008 and Suppl. Fig. S1). WHAMM
NA was present at low abundance in all lines tested, whereas
MY  is more variable reaching higher levels in some cell lines.
estern blot analyses of protein expression in lysates of selected
ell lines conﬁrmed a correlation between RNA and protein levels
n the corresponding lines using two different antibodies (Fig. 1b).
owever, all attempts to use these or other antibodies to deter-
ine the subcellular distribution of the endogenous protein by
mmunoﬂuorescence failed.
FP-tagged JMY  localizes to tubular vesicular endomembranesJMY  was described to affect motile processes in cells by directly
ltering actin dynamics at the leading edge (Zuchero et al., 2009)
nd indirectly through controlling cadherin levels (Coutts et al.,Cell Biology 93 (2014) 194–204
2009), but its mechanistic modes of action in vivo have remained ill
deﬁned. In case of a direct action of JMY  on driving actin assembly
at the cell periphery, a signiﬁcant accumulation at this subcellu-
lar location is expected. In the second scenario, the availability of
adhesion proteins can be controlled at the protein level, or in the
nucleus at the level of gene expression.
To unambiguously establish the subcellular localization of JMY
in adherent motile cells such as HeLa, cells ectopically expressing
low levels of GFP- or RFP-tagged full length JMY  were examined
by ﬂuorescence video microscopy. Interestingly, and reminiscent
of localization patterns observed for WHAMM, JMY  localized pri-
marily on tubulo-vesicular structures in the cell’s interior, but
neither in plasma membrane protrusions nor prominently in the
nucleus (Fig. 2A) under these conditions. These structures were ten-
tatively named endomembrane tubules (ETs). In some instances,
JMY-localization appeared cytoplasmic or in clouds (Fig. 2A, lower
panels), but detailed quantiﬁcation revealed that ET-localization
is the predominant type of localization, especially in low expres-
sors (Fig. 2B). It is worth mentioning that both JMY  ETs and ‘clouds’
were decorated with F-actin, as exempliﬁed by phalloidin staining
(Fig. 2A). These characteristics were not speciﬁc for one cell type,
but could be seen in all cells tested for JMY  localization (Suppl. Fig.
S2A). Since JMY- and actin-decorated ‘clouds’ were only observed
in the context of high levels of GFP-JMY expression, we  assume
they embody an experimental artefact an did not further consider
analysis of cells displaying this structure. In cells expressing JMY
close to the detection level, JMY  positive structures were not exces-
sively elongated and tubulated, but shorter or even rounded, yet
still deformed (Suppl. Fig. S2B). During visualization of GFP-JMY
dynamics in living cells, growth and shrinkage as well as move-
ment of ETs was observed (Suppl. Fig. S2C and Video 1). This was
to some extent reminiscent of what Campellone and colleagues
(Campellone et al., 2008) had described for the paralogous pro-
tein WHAMM.  Therefore, we wanted to test whether these two
related proteins might display overlapping localization patterns
probably sharing functions. To explore the possibility that JMY
and its relative WHAMM  act in the same cellular compartment,
we co-expressed GFP-tagged WHAMM  and mRFP-tagged JMY and
assessed their degree of co-localization (Fig. 2C). Strikingly, over-
lap of JMY  with WHAMM  was quite poor in these experiments.
Noteworthy though, JMY  did not prominently localize to ETs in
WHAMM  expressing cells, but appeared more cytoplasmic (Fig. 2C).
This result indicates that WHAMM  either competes with JMY  for
the same binding site or exerts a more indirect effect, somehow
interfering with JMY-mediated ET-formation. To test if JMY and
WHAMM  compete for binding to the same cellular compartment,
which might hinder co-localization, we probed JMY’s localizations
with the marker proteins ERGIC53 (Fig. 2D, upper panel, for ER-
Golgi intermediate compartment (Tang et al., 1995)), and GM130
(Fig. 2D, lower panel, for the cis-Golgi face (Nakamura et al., 1995)),
using immunoﬂuorescence. These subcellular locations have con-
vincingly been shown to be WHAMM-positive (Campellone et al.,
2008). Strikingly again, no signiﬁcant co-localization of JMY with
markers of the WHAMM-positive ERGIC/cis-Golgi-compartment
was detected. Nonetheless, under these conditions, GFP-JMY was
readily found on ETs, conﬁrming that the latter do not likely con-
stitute WHAMM-positive structures. Together, we conclude that
JMY  is active in a cellular compartment other than ERGIC and does
not signiﬁcantly overlap with the localization pattern established
earlier for WHAMM  (Campellone et al., 2008).ET-formation depends on actin assembly
To identify the domains needed for ET-localization/formation,
JMY  constructs lacking selected domains were employed (Fig. 3A).
K. Schlüter et al. / European Journal of Cell Biology 93 (2014) 194–204 197
Fig. 1. JMY  expression in cells and tissues. (A) Microarray analyses of cell lines as indicated showing the expression levels of three class I NPFs normalized to 1 for the highest
value.  Absolute numbers can be seen in supplemental Fig. S1. Note that WHAMM is a low abundant protein, while WASH and JMY  show low to moderate expression levels
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NA  levels. (C) Schematic domain overview of murine JMY  and WHAMM. WHAMM
airwise alignment using EMBOSS Needle reveals an identity score of 32% and a sim
ells expressing the respective GFP-tagged constructs were either
xed and stained for F-actin or inspected life.
The N-terminus of JMY  (AA1-403) localized to dot like struc-
ures reminiscent of vesicles, which showed the typical saltatory
ovement of cargo (Rapp et al., 1996) being transported on micro-
ubules (Fig. 3B; Suppl. Fig. S3, Video2). The shortest construct
howing this characteristic feature comprised amino acids 73–306
not shown). In contrast, JMY  fragments lacking the N-terminus-
ere mostly cytoplasmic and nucleoplamic (Fig. 3B bottom panel).
rom this we conclude that the endomembrane targeting of JMY
epends on its N-terminal region, which is similar to what has
een found for WHAMM  (Campellone et al., 2008). Noteworthy
owever, the N-termini of JMY  and WHAMM  are not conserved in
equence, corroborating that they target different endomembrane
ompartments in cells.
When truncating JMY  from the C-terminal side, its ability to
ssemble actin was gradually lost, as expected (Zuchero et al.,
009). Deletion of the acidic region reduces Arp2/3 complex activa-
ion, but leaves WH2-domain based actin ﬁlament assembly intact,
hile deletion of the entire VVVCA module fully abolishes JMY’s
ctin polymerizing activity (Zuchero et al., 2009). The acidic region
f class 1 NPFs carries a highly conserved tryptophane, also present
n JMY. For some NPFs including the paralogous WHAMM  protein,
utation of this tryptophane to alanin (WA  mutant) was  already
igniﬁcantly reduced in its ability to activate Arp2/3 (Campellone
t al., 2008). However, GFP-JMY W981A was not reduced in its abil-
ty to induce ETs (not shown). Moreover, JMY-A was  only slightly
educed in ET-formation (Fig. 3B and C) and both constructs still
arried F-actin on induced ETs, indicating that JMY’s actin poly-
erization ability was not abolished (Fig. 3B,C and data not shown).
inally, the VVVCA mutant did not induce any ETs and appeared
ainly cytoplasmic (Fig. 3B and C). Hence, neither cells express-
ng N  nor VVVCA displayed any ETs, while A  that should
e reduced in Arp2/3 activation was still able to assemble actin
laments, only showed a slight reduction in ETs. This is in line
ith earlier observations, in which a JMY  construct comprising the
H2-domains only, still effectively assembled actin independent tissues using 2 different antibodies. Note that protein levels correspond well with
roximately 200 AA shorter with the main gap being within the N-terminus. Global
y score of 46%. A detailed alignment is shown in Fig. S1D.
of Arp2/3 (Zuchero et al., 2009). From this we  conclude that both
membrane targeting via the N-terminus and actin assembly are
required for JMY  induced tubulation of endomembranes and thus
for ET-formation. Moreover, our data suggest that the WH2-domain
based actin assembly mechanism is sufﬁcient to drive ET formation.
This is distinct from WHAMM,  which can assemble actin ﬁlaments
solely in an Arp2/3 complex-dependent fashion, and requires the C-
terminal tryptophane for its proper cellular function (Campellone
et al., 2008).
We next tested the behaviour of JMY-decorated ETs upon
treatment with either nocodazole (noco) or latrunculin B (latB),
drugs that dissolve microtubules and actin ﬁlaments, respectively.
Despite the fact that the localizations of JMY  and WHAMM  do
not overlap, the effect of both drugs on JMY-decorated ETs was
virtually identical to that observed for WHAMM-positive tubular
vesicles (Campellone et al., 2008). More speciﬁcally, disruption of
microtubules stalled ET-movement and prohibited their de novo
formation, but did not affect the number and shape of existing ETs
(Suppl. Fig. S4A and B). In contrast, latB-treatment caused com-
plete rounding of ETs (Suppl. Fig. S4C). This is consistent with the
data obtained with expression of truncated JMY  variants, which
implied that actin ﬁlament assembly is essential for JMY-driven
endomembrane tubulation.
Overexpression of JMY  affects integrity of the Golgi network
JMY-positive ETs were mostly dispersed throughout the cell and
rarely accumulated in the perinuclear region. Since no overlap of
ETs with WHAMM  or cis-Golgi and Golgi-markers was  observed,
we expanded our studies to the trans-Golgi site. TGN46 is an estab-
lished marker for the trans-face of the Golgi apparatus (Hickinson
et al., 1997). Whereas JMY  did again not signiﬁcantly overlap with
TGN46 (Fig. 4A), we  observed a severe dispersion of the TGN46-
positive compartment in JMY-expressing cells, which gradually
increased with JMY’s expression level. In contrast, dispersal was not
observed for the cis-Golgi marker GM130 (Fig. 4B). In the rare case
of complete loss of TGN46-staining, JMY-positive ETs were also no
198 K. Schlüter et al. / European Journal of Cell Biology 93 (2014) 194–204
Fig. 2. JMY  localizes to endomembrane tubules (ETs). (A) Cos-7 or HeLa cells expressing GFP-tagged JMY  were ﬁxed and stained for F-actin. In the majority of cells, GFP-JMY
decorated tubular endosomes in addition to a moderate cytoplasmic background. We  tentatively named these structures ETs (endomembrane tubules). GFP-JMY was largely
excluded from the nucleus. JMY-positive tubular vesicles were motile (Video 1) and decorated with F-actin. In some cells expressing higher amounts of JMY, cloud-like
structures appeared (lower panels), which were also decorated with F-actin to varying extent. (B) A detailed quantiﬁcation of 300 cells from 3 independent experiments
revealed that in both cell types the predominant phenotype is ET-decoration (Cos7 57.7 ± 4.5% and HeLa 60.7 ± 2.1%), while cloud-like structures only appeared in low
numbers (9.3 ± 2.1% in Cos7 and 12 ± 4.4% in HeLa cells). In all other transfected cells, the staining was cytoplasmic. (C) Co-expression of JMY  with the distantly related
WHAMM  revealed no co-localization between the two  proteins. Noteworthy, in WHAMM/JMY double-expressing cells, neither ETs nor clouds were observed. (D) Cos-7 cells
expressing GFP-JMY were ﬁxed and stained for the cis-Golgi markers ERGIC53 and GM130 by indirect immunoﬂuorescence. Note that there is no co-localization between
JMY-positive ETs and these markers, staining the WHAMM-positive compartment (Campellone et al., 2008).
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Fig. 3. ET formation is actin dependent. (A) Domain overview of murine JMY  and constructs used in this study. The full length protein (FL) comprises 983 amino acids (AA),
the  N-terminus (NT) 403 AA, PP demarks the poly-proline stretch and V (=WH2) motifs are actin binding modules, C is the central connector region and A the Arp2/3-binding,
acidic  motif. JMY-A lacks 14 AA (1–969) and VVVCA lacks 160 AA (1–823). (B) Cos-7 cells expressing GFP-tagged JMY  variants as indicated were ﬁxed and stained for
F-actin. GFP-JMY (FL) and an Arp2/3 activation-defective delta-A variant decorate tubular endosomes, while no other construct can be seen on such elongated structures.
Delta-VVVCA, which is entirely defective in actin-assembly, as well as the isolated N-terminus (N-ter) can be found on dots, which may  constitute vesicles. However, these
are  never elongated and do not stain for F-actin (insets). The construct lacking the N-terminal domain (N, bottom panel) cannot target to rounded or elongated vesicles, and
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tppears either cytoplasmic or loosely associated with F-actin. Scale bar is 10 m.  (C
o  signiﬁcant difference between the frequency of ET formation in GFP-JMY FL and 
Ts  at all (0%).
onger observed. Quantiﬁcations revealed that disruption of Golgi
ntegrity is the predominant phenotype in GFP-JMY-expressing
ells, with more than 60% of transfected cells showing altered
GN46 distribution (Fig. 4C). Interestingly, GM130 staining and
hus the cis-Golgi face, was not or in the best case mildly affected.
gain this effect of JMY  was not cell type speciﬁc but occurred in
ll cell types tested. Since the TGN was affected by JMY-expression,
e speculated that JMY  might be involved in anterograde transport
rocesses depleting material from the trans-Golgi face.
To test if the observed ability of JMY  to induce ETs is
ausative of TGN-disruption, we expressed the same truncation
onstructs as described above (Fig. 3A), and analysed Golgi-
ntegrity using TGN46- and GM130-stainings. In accordance to
he results described above, JMY  expression only affected Golgintiﬁcation from 30 images of cells expressing the constructs as indicated revealed
pressing cells (94% of JMY-FL). All other constructs did not localize to or not induce
integrity with constructs harbouring the domains required for ET
formation (Fig. 4D and E). Absence of the N-terminus of JMY  (N)
not only completely failed to localize constructs in a JMY-typical
fashion, but also did not affect TGN46-distribution. In contrast,
when interfering with actin assembly-activities in the C-terminus,
the result was more complex in that a reduced actin polymerization
activity correlated with reduced Golgi-dispersal (Fig. 4D and E). It
was clearly observable that already a reduction of JMY’s ability to
activate Arp2/3 complex (A) resulted in some TGN-stabilization
(Fig. 4E), but TGN integrity was  fully maintained with constructs
incapable of actin assembly (VVVCA).
Together, expression of even low amounts of JMY  already effec-
tively disperses the Golgi from the trans- but not the cis-side.
This is in contrast to WHAMM,  which localizes to the ERGIC and
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Fig. 4. JMY affects Golgi integrity in actin-dependent fashion. (A) Cos-7 cells expressing either GFP or GFP-JMY were ﬁxed and stained for the trans-Golgi marker TGN46.
JMY  decorated ETs as expected. In GFP expressing cells, TGN46 staining is compact and in the perinuclear region. No co-localization between JMY  and TGN46 was seen.
However, in many cells, the trans-Golgi compartment was either dispersed throughout the cell or depleted as early as 16 h after transfection with GFP-JMY. Stages of TGN-
destruction are depicted from top to bottom. Scale bars are 10 m. (B) Cos-7 cells expressing either GFP or GFP-JMY were ﬁxed and stained for the cis-Golgi marker GM130.
GM130 displays a compact accumulation in the perinuclear region 16 h after transfection/expression of GFP or GFP-JMY. Scale bar is 10 m. (C) Quantiﬁcation from three
independent experiments of Cos-7 and HeLa cells showing non-compact or fully dispersed/depleted Golgi sub-compartments upon GFP-JMY expression. Values are from three
independent experiments analysing 100 cells each time. TGN46 staining is affected in 62 ± 4.4% in Cos-7 cells and 53.3 ± 2.5% in Hela Cells (p = 2.11E−07 and p = 2.92E−05,
respectively). Distortion of the cis Golgi compartment is either mild (13.7 ± 5.7% to 28.7 ± 5.5% in Cos 7, p = 0.005) or not detectable (9.3 ± 2.1% to 12 ± 5.3%, p = 0.46). (D) Cos-7
cells  expressing mutants of GFP-JMY as indicated were ﬁxed and stained for the trans-Golgi marker TGN46. Constructs lacking either the membrane-targeting N-terminus
(N)  or the actin assembling C-terminus (VVVCA) did neither distort the TGN nor colocalize with TGN46. JMY-A affected the TGN only mildly, despite the absence
of  clear co-localization (bottom panel). Scale bar is 10 m.  (E) Quantiﬁcation from three independent experiments of Cos-7 cells (100 each) with a non-compact or fully
dispersed/depleted TGN revealed that JMY-N and JMY-VVVCA are incapable of affecting TGN in a statistically signiﬁcant manner (14.2 ± 2.9% for GFP, 12.3 ± 2.1% for N
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Snd  14.7 ± 2.1% for VVVCA, p = 1). JMY-A affects the TGN only mildly (2 fold inc
4.5  fold to 62% ± 4.4%, p = 2.11E−07).
ffects Golgi-integrity from the cis-side (Campellone et al., 2008).
ogether, these results and the ones obtained from latB treatments
uggest that JMY-positive ETs affect or participate in an anterograde
ransport process that feeds away from the trans-Golgi network in
n actin-dependent fashion.
verexpression of JMY  affects VSV-G transportThe vesicular stomatitis indiana virus envelope glycoprotein G
VSV-G) is a transmembrane protein that can be used as a marker
or anterograde transport in eukaryotic cells (Presley et al., 1997;
cales et al., 1997). The ts045 mutant of VSV-G is a temperature from 14.3 to 31 ± 1%, p = 3.54E−05), while JMY-FL severely affects TGN46 staining
sensitive mutant that allows pulse chase experiments of GFP-VSV-
G transport. At the non-permissive temperature of 39.5 ◦C the
protein is translated but still trapped in the ER. At the permissive
temperature of 32 ◦C, the protein is properly folded leading to
transport of VSV-G on the anterograde route from the ER to the
Golgi apparatus and from there further to the plasma membrane.
For WHAMM  it was  described that both, overexpression and
suppression of expression by RNA-interference affects anterograde
VSV-G transport leading to accumulation in the ER (Campellone
et al., 2008). If JMY  plays a role in anterograde trans-Golgi trafﬁc,
JMY  expression should also affect VSV-G transport to the plasma
membrane. To test this hypothesis, we  monitored the amount of
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Fig. 5. JMY  expression affects VSV-G transport in HeLa cells. (A) HeLa cells were grown on glass cover slips and either transfected with GFP-VSV-G alone or co-transfected
with  GFP-VSV-G and myc-JMY. After incubation at 39.5 ◦C for 24 h, temperature was  shifted to 32 ◦C for 1 h to allow transport of VSV-G to the plasma membrane. Then the cells
were  ﬁxed and the VSV-G ectodomains in the plasma membrane were stained by secondary immunoﬂuorescence. Blue in merge is Dapi to stain for nuclei. Scale bar is 10 m.
(B)  Quantiﬁcation of VSV-G transport from microscopic images. Transport rate is given as the intensity ratio of the ectodomain staining (Iecto)/total GFP-VSV-G (IVSV-G). A
high  transport rate indicates that more GFP-VSV-G has reached the plasma membrane within 1 h. Data are expressed as box and whiskers plot. The median transport rate
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mor  myc-JMY expressing cells is 0.9 compared to 1.7 for control cells. For myc-JMY e
.1  to 2.6, respectively. The Error bars are given as 10th percentile for the lower an
ells  (control; GFP-VSV-G) from 3 independent experiments; p ≤ 0.001 determined
FP-VSV-G at the plasma membrane compared to the total amount
f GFP-VSV-G in control cells or cells expressing myc-tagged JMY
Fig. 5A) in pulse-chase experiments. Quantiﬁcation of the ﬂuores-
ent signal of VSV-G that reached the plasma membrane relative
o the entire GFP-VSV-G signal (Fig. 5B) revealed a strong reduc-
ion of transport in myc-JMY expressing cells. The mean transport
ate of GFP-VSV-G was  2.1 ± 0.09 for control cells compared to
.2 ± 0.152 (expressed as arithmetic means ± standard errors of
eans) in myc-JMY co-transfected cells, indicating a signiﬁcant
p ≤ 0.001) decrease in VSV-G transport caused by JMY  overex-
ression (Fig. 5B).
ass spectrometry to identify JMY  interaction partners
In order to learn more about the speciﬁc compartment JMY  is
ocalized to and about the cellular function it may  exert at this site,
e performed a proteomic screen for potential JMY  interactors. The
ethod has previously successfully been applied to identify WAVE-
omplex subunits (Derivery et al., 2009a) and WASH-interacting
roteins (Derivery et al., 2009b). JMY  was precipitated from 293
ells stably expressing His-PC-JMY using Ni-NTA beads. JMY  and
ts associated proteins were stained by Coomassie blue (Fig. 6A)
nd identiﬁed by mass spectrometry. Leading hits corresponding
o the numbered bands are given in the supplementary material
Table T2). All candidates from the measurement were assorted by
he cellular processes and compartments they are implicated in
ig. 6B. Finally, a shortlist of candidates likely to interact with JMY
n the cytoplasm was extracted.
Due to the localization of JMY  on endomembranes and its
ffect on Golgi integrity, we ﬁrst concentrated on three candidates,
nown to act on endomembranes: (i) the small GTPase termed Ras
omolog enriched in brain (RHEB), the sarcoplasmic/endoplasmic
eticulum calcium ATPase 2 (SERCA2), and the vesicle-associated
embrane protein-associated protein A (VAP-A).
SERCA2 is the ubiquitously expressed form of the endoplas-
ic  reticulum (ER) Ca(2+) pump, member of a three-gene familysing cells the 1st to 3rd quartile rages from 0.6 to 1.4 and for the control cells from
 percentile for the upper whisker. n = 116 cells (GFP-VSV-G + myc-JMY) and n = 90
e way ANOVA using SigmaPlot® (Systat Software).
in mammals (Vandecaetsbeek et al., 2011). SERCA2 catalyses the
translocation of calcium ions from the cytosol into the endoplasmic
reticulum lumen, and is involved in regulation of calcium depend-
ent myosin 2 activation/contraction. Mutations in this gene cause
Darier-White disease (Shull et al., 2011), an autosomal dominant
skin disorder characterized by loss of adhesion between epidermal
cells and abnormal keratinization.
RHEB is a canonical member of the Ras family of small GTPases
and binds to the tumour suppressor TSC1/TSC2 complex, where it
plays a role in regulating the insulin/TOR/S6K signalling pathway.
RheB is localized to Golgi and ER membranes (Hanker et al., 2010).
VAP-A belongs to a family of highly conserved integral endoplas-
mic  reticulum membrane proteins implicated in diverse cellular
functions, including the regulation of lipid transport (Holthuis and
Levine, 2005), membrane trafﬁcking, and the unfolded protein
response. VAP-A is a 33 kDa protein and comprises an N-terminal
immunoglobulin-like domain, a variable central coiled-coil domain
similar to that found in VAMPs and SNAREs, and a C-terminal
transmembrane- and dimerization domain (reviewed in Lev et al.,
2008). Different studies implicated VAP-A in regulating processes
at so called membrane contact sites (MCS), where it can connect
the ER to virtually any other membrane compartment (Levine and
Loewen, 2006). At these sites, VAP-A is binding to FFAT-motif con-
taining lipid-binding proteins (Loewen and Levine, 2005), a motif
however absent from JMY.
We  ﬁrst analysed the localization of SERCA2, RHEB and VAP-A
in the context of GFP-JMY expressing cells. In preliminary studies
no overlap between GFP-JMY and SERCA2 (Suppl. Fig. S5A) or RHEB
(Suppl. Fig. S5B) was detected. Hence, although we  cannot exclude
an interaction at this point, we next concentrated on VAP-A.
JMY interacts and co-localises with VAP-AVAP-A localized to the ER endomembrane-network when
expressed as a ﬂuorescently tagged fusion protein, as described
earlier (Kawano et al., 2006). Colocalization of GFP-VAP-A with
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Fig. 6. Mass spectrometry to identify JMY  interaction partners. (A) 293 cells stably expressing His-PC-JMY or the empty plasmid were lysed and subjected to two  steps
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ndicated on the left and identiﬁed candidates on the right. (B) Classiﬁcation of the 
f  JMY, we concentrated on candidate proteins that are associated with the cellular
he  supplemental material.
he ER-marker GFP-ER (Fig. 7A) is virtually complete labelling
he complete peripheral ER network. When co-expressed with
uorescently-tagged JMY, GFP-JMY decorated ETs entirely over-
apped with mCherry-VAP-A labelled subcompartments of the
R (Fig. 7B). The colocalization was very distinct and neither
ctopic expression of mCherry VAP-A nor of GFP-JMY signiﬁcantly
nﬂuenced the pattern displayed upon single expression of either
ig. 7. JMY  physically interacts and colocalises with VAP-A. (A) Cos-7 cells co-expressing
xed  and inspected. VAP-A overlaps virtually completely with the endoplasmic reticulu
ells  co-expressing mCherry-tagged VAP-A (mCh-VAP-A) and GFP-JMY were ﬁxed and a
rom  when expressed alone. GFP-JMY decorated ETs however completely overlapped wit
verlap. Scale bar is 10 m. (C) Immuno-precipitations from COS-7 cells expressing myc-ta
ut  not GFP alone co-precipitated with myc-JMY in myc-IPs, further corroborating an inte blue and identiﬁed by mass spectrometry. Molecular weight markers in kDa are
ﬁed potential interactors by function and cell compartment. Given the localization
membrane system (red). A more complete list of the classiﬁed hits can be found in
construct. Hence, we  assume that the sites of colocalization
embody MCS, which is also in line with the fact that JMY is
localized to a post-Golgi compartment. To further corroborate
the potential interaction between VAP-A and JMY, we  per-
formed immuno-precipitations. Indeed, GFP-tagged VAP-A was
reproducibly co-precipitated with myc-tagged JMY  (Fig. 7C),
albeit at low efﬁciencies. Given the fact however, that the MCS
 mCherry-tagged VAP-A (mCh-VAP-A) and the ﬂuorescent ER-marker GFP-ER were
m (ER) network which is spread throughout the cell. Scale bar is 10 m.  (B) Cos-7
nalysed for the degree of colocalization. Both proteins localized indistinguishable
h the respective parts of the ER. Not a single JMY-positive ET was found lacking this
gged JMY  and either GFP or GFP-VAP-A. Low, but signiﬁcant amounts of GFP-VAP-A
eraction of these two  proteins.
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Fig. 8. JMY  is driving vesicle trafﬁc in a unique cellular compartment. (A) Arp2/3 activators were assigned predominant sites of activity in the cell. We here propose a model in
which  JMY  is placed in anterograde transport processes away from the trans-Golgi face, involving membrane contact sites with the endoplasmic reticulum. WASH-complex
is  important for a subset of endosomal transport processes, and prohibits microtubule motor-mediated endosome elongation/tubulation. In contrast, JMY  actively stimulates
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besicle tubulation. WHAMM  is involved in regulating vesicular transport processes 
oated-pit internalization, and vesicle rocketing. WAVE-complex drives formation 
ompartment is representing only a small fraction of the VAP-A-
abelled ER, and that we might only look at the fraction of JMY
ocalized to ETs, leaving out cytoplasmic JMY  and any other type of
MY-localization, we interpret this result as speciﬁc. Together, JMY
nteracts with VAP-A in co-immunoprecipitations and TAP-taggig-
xperiments corroborating that both proteins exist together in a
omplex. Moreover JMY  and VAP-A colocalise in speciﬁc cellular
ites.
onclusions
JMY  is localized to an endomembrane compartment that com-
unicates with both, the ER and vesicles derived from the
rans-Golgi face. GFP-JMY decorated endomembrane tubules (ETs)
re somewhat reminiscent of post-Golgi pleomorphic carriers
Anitei and Hoﬂack, 2011; Anitei et al., 2010b), which have been
escribed to be at play in a plethora of transport processes
Polishchuk et al., 2003; Waguri et al., 2003; Yeaman et al., 2004).
oreover, the actin regulatory proteins Cyﬁp1, -2/Sra1/Pir121 and
ASP/N-WASP were recently implicated in the biogenesis of these
arriers (Anitei et al., 2010a) but neither protein decorated these
ubular vesicles as observed here for JMY. Together, these struc-
ures may  likely embody post Golgi-carriers that interact with
he peripheral ER at MCS. JMY-mediated actin assembly results
n the elongation and tubulation of this compartment, as dele-
ion of its C-terminus, which harbours the domains required for
rp2/3 dependent and independent actin assembly, results in loss
f tubulation. We  also show that reduction of the Arp2/3-driven
athway of actin assembly does not signiﬁcantly alter the observed
henotype. Tubule formation and F-actin decoration of ETs both
each almost control levels seen with full-length JMY  (FL-JMY) in
ells expressing a construct reduced in Arp2/3 activation (A).
onetheless, in contrast to WHAMM,  which is particularly sen-
itive to mutations in the C-terminus concerning its ability to
ctivate Arp2/3 (Campellone et al., 2008), we cannot exclude that
his JMY-construct still retained some activity, as also shown for
orresponding N-WASP constructs (Delatour et al., 2008; Oelkers
t al., 2011).
Ectopic expression of GFP- (and mCherry-) tagged JMY  does not
nly result in the decoration of tubular vesicular structures with
-actin and JMY, but also affects the integrity of the Golgi appara-
us. Cells ectopically expressing GFP-tagged JMY  show a dispersal
f Golgi material from the trans-Golgi face, as exempliﬁed by a suc-
essive loss up to complete disappearance of TGN46 (a trans-Golgi
arker) positive material, while GM130 (cis-Golgi marker) posi-
ive material is not signiﬁcantly affected. This effect depends on
oth ET-formation and JMY-mediated actin assembly, as shown by cis-Golgi and ERGIC region, whereas N-WASP was  found to operate during clathrin
ellipodial cell protrusions.
deletion mutants that are incapable of actin assembly and leaving
the Golgi intact. From this we  conclude that JMY  is at play in trans-
port processes driving vesicle trafﬁc, most likely anterograde, away
from the trans-Golgi network.
JMY  is a member of a two-gene family and its closest relative
is a protein called WHAMM  (Rottner et al., 2010). WHAMM  has
been shown to drive vesicle trafﬁc in the compartment between
ER and Golgi (termed ERGIC: ER Golgi Intermediate Compart-
ment) (Campellone et al., 2008). We  here provide evidence that
JMY- and WHAMM-positive compartments do not overlap sig-
niﬁcantly. This is further conﬁrmed by a lack of co-localization
with markers of the WHAMM  positive cis-Golgi compartment,
ERGIC53 and GM130. Nevertheless, WHAMM and JMY  apparently
inﬂuence each other since cells expressing WHAMM do not show
JMY-decorated ETs. We  interpret this phenomenon as a secondary
effect of WHAMM  expression, since both WHAMM  expression as
well as WHAMM  ablation were shown to block trafﬁc through
the ERGIC (Campellone et al., 2008) leading to Golgi depletion
from the cis-side. Hence, after prolonged expression of WHAMM,
material for JMY-based transport might vanish due to trapping in
the ER.
Finally, with the aim to better understand the JMY-positive com-
partment and its biological role, we ﬁshed for new interaction
partners. Using a mass spectrometry approach, we revealed a num-
ber of potential candidates, one of which, VAP-A, we  here validate as
JMY-binding partner. VAP-A is a protein that acts in connecting ER-
membranes to many other cellular membrane-compartments by
forming so-called membrane contact sites (MCS)(Lev et al., 2008;
Levine and Loewen, 2006). One function of VAP-A, which has been
elucidated in more detail in the past, is the transport of ceramide
from the smooth ER, where it is synthesized, to the plasma mem-
brane by interacting with CERT (Peretti et al., 2008). However, the
multiple functions of VAP-A are just being unravelled and it may  be
important for regulating many processes in MCS. Together, JMY  is
involved in transport processes, which involve the actin dependent
elongation/tubulation of vesicles. This is a unique function, also in
contrast to WASH, another Arp2/3-activator of endosomal vesicles,
which can prohibit motor-protein induced vesicle elongation and
promotes protein sorting by local actin assembly (Derivery et al.,
2009b; Duleh and Welch, 2010).
Ectopic expression of JMY  leads to exaggerated transport and
dispersal of trans-Golgi-derived material until the TGN is depleted.
We propose a model in which JMY  targets to a unique subcell-
ular compartment, exerting a unique function not seen by any
other Arp2/3-activator on endomembranes (Fig. 8). In this compart-
ment JMY  drives vesicular trafﬁc that is JMY-speciﬁc, but intimately
interconnected to transport processes driven by other Arp2/3-
activators such as WHAMM.  This may  also explain for the effects of
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MY  expression levels on cell motility (Coutts et al., 2009; Zuchero
t al., 2009), as we did not ﬁnd any sign of direct action such
s co-localization of JMY  with motile organelles like lamellipodia.
inally, it will be tempting to probe for a role for JMY  in trafﬁc-
ing of adhesion molecules, since JMY-ablation has been described
o affect cadherin levels (Coutts et al., 2009). The exact function
hat JMY  has on endomembranes and the speciﬁc requirements
or Arp2/3-dependent and -independent actin assembly in the pro-
esses driven by JMY  remain to be elucidated.
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